COMMUNIQUÉS West-GlobeNewswire

Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion
18/10/2018
Novartis to acquire Endocyte for $24 per fully diluted share in cash PSMA-617 to enhance Novartis’ industry-leading radio-ligand therapy platform WEST LAFAYETTE, Ind., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. ( [...]
Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms
18/10/2018
Novartis to acquire Endocyte to accelerate development of innovative radioligand technology for treating cancer Acquisition would add 177 Lu-PSMA-617 , a potential first-in-class radioligand therapy in Phase III [...]
Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth
18/10/2018
Net sales grew 6% (cc[1], +3% USD) mainly driven by: Cosentyx grew to USD 750 million (+37% cc) with strong volume growth across indications Entresto more than doubled to USD 271 million (+113% cc) driven by continued [...]
Novartis a enregistré, au troisième trimestre, une forte croissance et fait preuve d'une innovation dynamique, incluant des plateformes thérapeutiques avancées pour soutenir la croissance future
18/10/2018
Hausse du chiffre d'affaires net de 6% (tcc[1], +3% USD), stimulée principalement par: Cosentyx , qui a progressé à USD 750 millions (+37% tcc) grâce à une forte croissance en volume dans toutes ses indications Entresto [...]
Aclaris Announces Pricing of Public Offering of Common Stock
18/10/2018
WAYNE, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering
18/10/2018
BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of its initial public offering of 6,650,000 ordinary shares at [...]
Abattis Bioceuticals Celebrates Legalization
18/10/2018
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to celebrate the legalization of cannabis in Canada. This is a [...]
PhaseBio Announces Pricing of Initial Public Offering
18/10/2018
MALVERN, Pa. and SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Meridian Bioscience to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on November 8, 2018
17/10/2018
CINCINNATI, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials will report fourth quarter and full year 2018 financial [...]
Kane Biotech Announces New Manufacturing Partner for bluestem™ Product Line
17/10/2018
Strategic Partnership Reduces Annual Overhead Costs by More than C$200,000 WINNIPEG, Manitoba, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) , today [...]
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
17/10/2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association [...]
IntelGenx Announces Proposed Equity Offering
17/10/2018
SAINT LAURENT,, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) today announced that it intends to distribute units (the “ Units ”), each Unit [...]
OpGen Announces Proposed Public Offering of Common Stock
17/10/2018
GAITHERSBURG, Md., Oct. 17, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are being offered by OpGen, [...]
Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors
17/10/2018
MENLO PARK, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Marrone Bio Innovations Appoints Barner Jones as New Director of National Sales and Account Management
17/10/2018
DAVIS, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Barner Jones [...]
Inspire Medical Systems, Inc. Announces Presentation of Clinical Efficacy Data for Inspire Therapy for Treatment of Obstructive Sleep Apnea at Annual ENT Surgeon Conference
17/10/2018
Data Includes Treatment Effect of Inspire Therapy in Medicare-aged Population Compared with Younger Patients MINNEAPOLIS, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a [...]
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
17/10/2018
PITTSBURGH, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS) (the “Company”), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from [...]
Aclaris Announces Proposed Public Offering of Common Stock
17/10/2018
WAYNE, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Bone Therapeutics annonce que son viscosupplément JTA-004 a montré une réduction de la douleur supérieure au traitement standard dans une première étude clinique en arthrose du genou
17/10/2018
Communiqué de presse Les résultats encouragent la poursuite du développement clinique, élargissent le portefeuille de produits et s’inscrivent dans une série de résultats positifs pour la Société Gosselies, Belgique, 17 [...]

Pages